Incidence and prognosis of taxane-induced macular edema: a retrospective study from the Japan Clinical REtina Study Group (J-CREST)

Abstract Macular edema is a known side effect of taxane-based anticancer drugs. We retrospectively investigated data from 11 centers between January 2016 and December 2021. Among 14,260 patients, 30 (0.21%) developed macular edema; from these, the number of cases associated with nab-paclitaxel was 1...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Hiroki Tsujinaka, Sho Imoto, Tetsuo Ueda, Makiko Wakuta, Yutaka Yamada, Takaaki Sugisawa, Fumiko Murao, Takao Hirano, Shigeo Yoshida, Kumiko Kato, Mariko Sasaki, Riko Matsumoto, Gaku Ishigooka, Nahoko Ogata
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Nature Portfolio 2024-08-01
Edice:	Scientific Reports
Témata:	Taxane-based anticancer drugs Macular edema Incidence
On-line přístup:	https://doi.org/10.1038/s41598-024-69775-9
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!